mechanism 669 words KG: Als
Contents

mitochondrial-dysfunction-als

Mechanism Info
NameAls
Key Genes/Proteins5-HT1AR, 6-OHDA, A2M, AADC, ABCA1, ABCA2

No AI portrait yet

Knowledge Graph

Agent Input

Related Hypotheses (137)

SASP-Mediated Complement Cascade Amplification
Score: 0.98
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.98
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.97
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.82
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.79
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.78
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.77
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Senescent Cell Mitochondrial DNA Release
Score: 0.74
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
Epigenetic Memory Erasure via TET2 Activation
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.74
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73
TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.73
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.72
Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.72
HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
Autophagosome Maturation Checkpoint Control
Score: 0.71
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.71
← Prevpg 4/7Next →

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed

Related Experiments (25)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

See Also (2)

A2M Gene
gene · KG edge: interacts_with
ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates

Knowledge Graph (12 edges)

VEGFA associated_with Als
EEF1A1 associated_with Als
LDLR associated_with Als
TFR1 associated_with Als
TREM2 associated_with Als
JUN associated_with Als
CLOCK associated_with Als
COMT associated_with Als
PARK7 associated_with Als
BDNF associated_with Als

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...